Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk?

Risultato della ricerca: Contributo su rivista › Commento

Accesso al documento

@article{e753da7427ea42ca92e76f7636b5cef1,

title = "Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk?",

author = "Cristina Rigamonti and Sadahisa Ogasawara",

year = "2018",

month = jun,

doi = "10.1016/j.dld.2018.03.025",

language = "English",

volume = "50",

pages = "580--582",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "Elsevier BV",

number = "6",

}

TY - JOUR

T1 - Hepatocellular carcinoma after direct-acting antiviral agents

T2 - Can liver stiffness kinetics help identify patients at lower risk?

AU - Rigamonti, Cristina

AU - Ogasawara, Sadahisa

PY - 2018/6

Y1 - 2018/6

UR - https://www.scopus.com/pages/publications/85045553739

U2 - 10.1016/j.dld.2018.03.025

DO - 10.1016/j.dld.2018.03.025

M3 - Comment/debate

SN - 1590-8658

VL - 50

SP - 580

EP - 582

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

IS - 6

ER -